QBIView assesses whether a biological product is supported by evidence, across seven readiness layers scored independently.
QBIView is an independent, named diligence verdict on a specific biological product or company, scored against seven readiness layers, with a qualified scientist accountable for the call. Three products, from a self-serve diagnostic to expert-led due diligence.
QBIView · Assessment
sample- Biological Validity82
- Product Integrity74
- Field Translation61
- Regulatory Pathway88
- Commercial Viability55
- Organizational & IP70
- R&D and Governance79
What QBIView assesses
Evidence sufficient to support a claim on paper may still be insufficient to predict performance under field conditions. QBIView applies structured judgment to that distinction, and attaches a named assessor to the call.
The framework
Seven readiness layers, each scored on its own.
Every QBIView assessment scores a biological product or company across the same seven layers. Each is scored independently so weaknesses do not hide behind strengths.
- 01Biological Validity
- 02Product Integrity
- 03Field Translation
- 04Regulatory Pathway
- 05Commercial Viability
- 06Organizational & IP Strength
- 07R&D and Governance
The ladder
Three products. One framework.
01
QBIView Rapid
Self-serve
A structured diagnostic. Instant scored report with Go / Conditional / No-Go signal across the seven QBIView pillars.
Best for: Founders stress-testing their own science, investors triaging a deal, researchers exploring commercialization.
02
QBIView Standard
Consultative · request a quote
Full seven-pillar assessment with uncertainty intervals and a final scored narrative. The questionnaire is completed by the submitting organisation. The report is written and signed by Dr. de Quadros and delivered with a debrief call.
Best for: Companies preparing for fundraising or partnership, investors doing serious diligence on their own.
03
QBIView Standard + Advisory
Consultative · request a quote
Expert-led version of the Standard assessment. Founder interview, data room review, IP and regulatory analysis, scenarios, QBI Verdict (Go / Conditional / No-Go), and deal-term recommendations. Includes debrief call with Dr. Patrícia Dörr de Quadros.
Best for: Investors making a large commitment; corporate strategics evaluating acquisition or licensing; companies preparing for IC review.
Confidential by default. Not sold. Not published. Not shared without permission.
Choosing a tier
Tier is assigned on scope.
Tell us the question you are trying to answer and the decision you are facing. We come back with the right QBIView product and a quote.